Deciphera Pharmaceuticals, Inc.
DCPHDelisted Jun 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001654151
Deciphera Pharmaceuticals, Inc. was delisted on Jun 11, 2024; its insiders filed their last Form 4 on Jun 11, 2024; 177 institutions reported holding it in 13F filings for Q1 2024, worth $943.7M in total; no superinvestor held it.
Holders of 5% or more of DCPH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Deciphera Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Deciphera Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
37 Schedule 13D and 13G filings on Deciphera Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2024 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Braidwell LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2024 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Brightstar Associates LLC | 13G/AOld format | – | – | – | SEC |
| Feb 6, 20244:52 PM ET | Goldman Sachs Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 26, 202411:49 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 23, 2024 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Mar 22, 2023 | Flynn James E | 13GOld format | – | – | – | SEC |
| Feb 14, 2023 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Braidwell LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Bank of America Corp | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 20239:52 AM ET | Goldman Sachs Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | Brightstar Associates LLC | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20234:27 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2023 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Jul 11, 2022 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| May 9, 2022 | Redmile Group, LLC | 13GOld format | – | – | – | SEC |
| Feb 15, 2022 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20224:41 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2022 | Franklin Resources Inc | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20221:03 PM ET | Goldman Sachs Group Inc | 13GOld format | – | New | – | SEC |
| Jan 31, 2022 | Bank of America Corp | 13GOld format | – | New | – | SEC |
| Jan 10, 2022 | State Street Corp | 13GOld format | – | New | – | SEC |
| Nov 10, 2021 | Flynn James E | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 2, 20213:13 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Feb 1, 2021 | Franklin Resources Inc | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
1 notice from officers, directors and other affiliates planning to sell Deciphera Pharmaceuticals, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 30, 20236:05 PM ET | Martin Daniel C.Officer | 17.8K | $223.8K | Nov 30, 2023 | Morgan Stanley Smith Barney LLC Executive Services | SEC |